A detailed history of Greytown Advisors Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Greytown Advisors Inc. holds 1,513 shares of JNJ stock, worth $235,226. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,513
Previous 1,874 19.26%
Holding current value
$235,226
Previous $296,000 25.34%
% of portfolio
0.13%
Previous 0.17%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $52,121 - $56,958
-361 Reduced 19.26%
1,513 $221,000
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $93,908 - $98,457
-605 Reduced 24.41%
1,874 $296,000
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $1,019 - $1,112
7 Added 0.28%
2,479 $388,000
Q3 2023

Nov 06, 2023

SELL
$155.75 - $174.48 $173,972 - $194,894
-1,117 Reduced 31.12%
2,472 $385,000
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $154 - $166
1 Added 0.03%
3,589 $594,000
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $54,831 - $65,434
-363 Reduced 9.19%
3,588 $556,000
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $95,799 - $107,514
-598 Reduced 13.15%
3,951 $697,000
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $179,560 - $199,805
-1,113 Reduced 19.66%
4,549 $743,000
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $138,756 - $153,458
-825 Reduced 12.72%
5,662 $1.01 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $309,163 - $351,098
-1,955 Reduced 23.16%
6,487 $1.15 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $44,284 - $49,134
-284 Reduced 3.25%
8,442 $1.44 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $168,767 - $187,546
1,045 Added 13.6%
8,726 $1.41 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $253,892 - $272,343
1,592 Added 26.15%
7,681 $1.27 Million
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $175,112 - $195,029
1,144 Added 23.13%
6,089 $1 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $206,898 - $237,486
1,509 Added 43.92%
4,945 $778,000
Q3 2020

Nov 16, 2020

BUY
$140.38 - $153.83 $165,508 - $181,365
1,179 Added 52.24%
3,436 $512,000
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $181,364 - $218,958
-1,408 Reduced 38.42%
2,257 $317,000
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $346,423 - $479,986
-3,117 Reduced 45.96%
3,665 $481,000
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $9,690 - $11,129
-76 Reduced 1.11%
6,782 $989,000
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $31,356 - $35,108
247 Added 3.74%
6,858 $887,000
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $62,033 - $68,225
-473 Reduced 6.68%
6,611 $921,000
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $35,830 - $39,840
-285 Reduced 3.87%
7,084 $990,000
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $2,702 - $3,252
22 Added 0.3%
7,369 $951,000
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $189,056 - $222,178
-1,555 Reduced 17.47%
7,347 $1.02 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $89,788 - $99,083
752 Added 9.23%
8,902 $1.08 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $48,038 - $56,885
384 Added 4.94%
8,150 $1.04 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $77,288 - $84,592
589 Added 8.21%
7,766 $1.09 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $929,206 - $971,622
7,177
7,177 $933,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Greytown Advisors Inc. Portfolio

Follow Greytown Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greytown Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greytown Advisors Inc. with notifications on news.